Showing results (101-110 of 130) with videos related to
Sort By:
Pageof 13
Bone Marrow Transplantation|January 6, 2004
A novel preparative regimen for autologous transplant in non-Hodgkin's lymphoma: long-term experience with etoposide and thiotepaA G McCoy, E P Smith, M E Atkinson, et al.Medrxiv : the Preprint Server for Health Sciences|June 25, 2020
Plasma from recovered COVID19 subjects inhibits spike protein binding to ACE2 in a microsphere-based inhibition assayEdward P Gniffke, Whitney E Harrington, Nicolas Dambrauskas, et al.The New England Journal of Medicine|October 20, 1994
Estrogen resistance caused by a mutation in the estrogen-receptor gene in a manE P Smith, J Boyd, G R Frank, et al.Blood|August 1, 1995
The outcome of matched unrelated donor bone marrow transplantation in patients with hematologic malignancies using molecular typing for donor selection and graft-versus-host disease prophylaxis regimen of cyclosporine, methotrexate, and prednisoneA Nademanee, G M Schmidt, P Parker, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1994
Prediction of systemic fungal infection in allogeneic marrow recipients: impact of amphotericin prophylaxis in high-risk patientsM R O'Donnell, G M Schmidt, B R Tegtmeier, et al.Circulation|December 13, 1997
Premature coronary artery disease associated with a disruptive mutation in the estrogen receptor gene in a manK Sudhir, T M Chou, K Chatterjee, et al.Science Signaling|May 5, 2021
Remodeling of the Homer-Shank interactome mediates homeostatic plasticityWhitney E Heavner, Jonathan D Lautz, Haley E Speed, et al.Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|April 29, 1998
Immortalization and characterization of bone marrow stromal fibroblasts from a patient with a loss of function mutation in the estrogen receptor-alpha geneS C Dieudonné, T Xu, J Y Chou, et al.Blood|March 1, 1995
High-dose chemotherapy with or without total body irradiation followed by autologous bone marrow and/or peripheral blood stem cell transplantation for patients with relapsed and refractory Hodgkin's disease: results in 85 patients with analysis of prognostic factorsA Nademanee, M R O'Donnell, D S Snyder, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1994
High-dose therapy followed by autologous peripheral-blood stem-cell transplantation for patients with Hodgkin's disease and non-Hodgkin's lymphoma using unprimed and granulocyte colony-stimulating factor-mobilized peripheral-blood stem cellsA Nademanee, I Sniecinski, G M Schmidt, et al.Pageof 13